Ulcerative Colitis Clinical Trials in Guangzhou, Guangdong
14 recruitingGuangzhou, Guangdong, China
Showing 1–14 of 14 trials
Recruiting
Phase 2
A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis
Ulcerative Colitis
Sanofi99 enrolled67 locationsNCT06975722
Recruiting
Not Applicable
Efficacy and Safety of Vedolizumab Combined With Upadacitinib in Patients With Ulcerative Colitis
Ulcerative Colitis (UC)
Sixth Affiliated Hospital, Sun Yat-sen University334 enrolled1 locationNCT06095596
Recruiting
Phase 2
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis
Takeda207 enrolled141 locationsNCT06254950
Recruiting
Phase 2
Study Evaluating ISM5411 Administered Orally to Subjects With Active Ulcerative Colitis (BETHESDA)
Ulcerative Colitis
InSilico Medicine Hong Kong Limited80 enrolled28 locationsNCT07265570
Recruiting
Phase 3
A Study to Assess the Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis Treated With Risankizumab Compared to Vedolizumab
Ulcerative Colitis
AbbVie530 enrolled270 locationsNCT06880744
Recruiting
Real-World Effectiveness and Safety of Upadacitinib Plus Vedolizumab vs Upadacitinib Monotherapy During Induction in Moderate-to-Severe Ulcerative Colitis
Ulcerative Colitis (UC)
Sixth Affiliated Hospital, Sun Yat-sen University150 enrolled1 locationNCT07442045
Recruiting
Phase 2
A Phase 2 Study to Evaluate the Efficacy, Safety and Pharmacokinetics of SHR-1139 in Patients With Moderate-to-severe Active Ulcerative Colitis
Adult Patients With Moderately to Severely Active Ulcerative Colitis
Guangdong Hengrui Pharmaceutical Co., Ltd20 enrolled1 locationNCT07232576
Recruiting
Phase 2
A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
Crohn's DiseaseUlcerative Colitis
Takeda183 enrolled16 locationsNCT06764615
Recruiting
Phase 3
Efficacy and Safety of Vedolizumab IV in Chinese Participants With Ulcerative Colitis
Moderately to Severely Active Ulcerative Colitis
Takeda402 enrolled36 locationsNCT03221036
Recruiting
An Observational Study to Evaluate Effectiveness and Safety of Upadacitinib in Chinese Adult Participants With Moderate to Severely Active Ulcerative Colitis (UC)
Ulcerative Colitis
AbbVie80 enrolled3 locationsNCT06838845
Recruiting
Phase 1Phase 2
A Study of AC-101 Tablets in Participants With Moderate to Severe Active Ulcerative Colitis
Ulcerative Colitis
Accro Bioscience (Suzhou) Limited24 enrolled1 locationNCT07083193
Recruiting
Efficacy and Safety of Upadacitinib in Inflammatory Bowel Disease
Crohn's DiseaseUlcerative ColitisInflammatory Bowel Disease
Xiang Gao174 enrolled6 locationsNCT06780683
Recruiting
Phase 4
The Efficacy and Safety of Combining Probiotic VSL#3 With Vedolizumab for the Treatment of Moderate Ulcerative Colitis
Ulcerative Colitis
Second Affiliated Hospital, School of Medicine, Zhejiang University100 enrolled12 locationsNCT06609447
Recruiting
Phase 2Phase 3
Fecal Microbiota Transplantation for Ulcerative Colitis
Ulcerative ColitisFecal Microbiota Transplantation
Guangzhou First People's Hospital120 enrolled1 locationNCT03804931